The clinical course of symptomatic deep vein thrombosis after 3 months of anticoagulant therapy using fondaparinux/edoxaban or fondaparinux/vitamin K antagonist

BACKGROUND: For the management of venous thromboembolism (VTE), providing anticoagulant therapy within the therapeutic range has been a major challenge, as conventional therapy with unfractionated heparin (UFH) and vitamin K antagonist (VKA) requires frequent laboratory monitoring and dose adjustmen...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Ther Clin Risk Manag
मुख्य लेखकों: Shimizu, Kazuhiro, Iiduka, Takuo, Sato, Shuji, Kiyokawa, Hajime, Nakagami, Takahiro, Mikamo, Hiroshi, Kawazoe, Masayo, Takahashi, Mao, Noro, Mahito
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Dove Medical Press 2018
विषय:
Original Research
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC5827747/
https://ncbi.nlm.nih.gov/pubmed/29503557
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TCRM.S153517
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन